FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Says Bellavista Ventilator Recall is Class 1

FDA says a Vyaire Medical recall of 2,605 Bellavista ventilators due to a software configuration issue is Class 1.

Human Drugs

FDA Defers New Drug Manufacturing Reporting Deadline

FDA defers a 2/15 deadline on new annual drug manufacturing reporting that were mandated by the CARES Act to help the agency get a handle on potential...

Marketing

Variability in Sex-Based Drug Difference Info

University of Maryland researchers find substantial variability in information on sex-based differences in drug safety and efficacy for drugs approved...

Human Drugs

Acadia Re-files Nuplazid sNDA for Alzheimers

Acadia Pharmaceuticals resubmits a supplemental NDA for Nuplazid (pimavanserin) for treating hallucinations and delusions associated with Alzheimers d...

Medical Devices

FDA OKs Avita Recell System PMA Supplement

FDA approves an Avita Medical PMA supplement for an enhanced version of its Recell system.

FDA General

Califf Sworn In as FDA Commissioner

Robert Califf begins his second tour as FDA commissioner after being sworn in 2/17.

Medical Devices

Tandem App Cleared for Bolus Insulin Dosing

FDA clears a Tandem Diabetes Care 510(k) for bolus insulin dosing on the t:slim X2 insulin pump using the t:connect mobile app.

Federal Register

Companion Animal Antimicrobial Use Comments Sought

Federal Register notice: FDA seeks comments about antimicrobial drug use practices in companion animals and the potential impacts on antimicrobial res...

Federal Register

Workshop on Generic Drug Research Initiatives

Federal Register notice: FDA announces a 5/9-10 public workshop entitled FY 2022 Generic Drug Science and Research Initiatives Workshop.

Human Drugs

FDA Advisors Nix IV Tramadol

Members of two FDA advisory committees say Avenue Therapeutics IV Tramadol has risks that exceed benefits.